𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti–tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders

✍ Scribed by Karen B. Onel; Kenan Onel


Publisher
Wiley (John Wiley & Sons)
Year
2010
Tongue
English
Weight
66 KB
Volume
62
Category
Article
ISSN
2151-464X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Neutropenia in patients receiving anti–t
✍ Richard Hastings; Tina Ding; Sayqa Butt; Kate Gadsby; Weiya Zhang; Robert J. Moo 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## Objective To examine the rates of and risk factors for neutropenia together with the dynamics of neutrophil and other white cell subset counts in a cohort of patients treated with a tumor necrosis factor (TNF) inhibitor for inflammatory arthritis. ## Methods We performed a retrosp

Genotoxicity of anti–tumor necrosis fact
✍ Erkan Demirkaya; Ismet Cok; Emre Durmaz; Onur K. Ulutas; Nuray Aktay Ayaz; Nesri 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 153 KB 👁 2 views

## Abstract ## Objective To assess the possible effects of both inflammation and the anti–tumor necrosis factor agents (anti‐TNF) on DNA damage with a specific assay, and their effects on the repair capacity of DNA. ## Methods From a group of 20 children with juvenile idiopathic arthritis (JIA),

Anti–tumor necrosis factor therapy in pa
✍ Gary S. Hoffman; Peter A. Merkel; Richard D. Brasington; Deborah J. Lenschow; Pa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

## Abstract ## Objective Granulomatous inflammation is a typical feature of Takayasu arteritis (TA), and tumor necrosis factor (TNF) is important in the formation of granulomas. In this study, we assessed therapy with anti‐TNF agents in patients with TA that was not controlled by glucocorticoid th

Anti–tumor necrosis factor α therapy and
✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif